03/25/2013 - 12:00pm

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

03/25/2013 - 10:51am

More than 400 drugs are under development for the 10 most common chronic health conditions affecting elderly people, according to a new report by a drug industry trade group.

03/25/2013 - 10:14am

Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.

03/25/2013 - 9:25am

An early look at this season’s reports indicates that about 90% of flu-related pediatric deaths occurred in children who had not received a flu vaccination this season, the Centers for Disease Control and Prevention reported.

03/22/2013 - 1:30pm

A drug made by Novo Nordisk for Type 2 diabetes produced a 6% loss of weight in a trial of the drug in obese patients, the company said.

03/22/2013 - 11:37am

AstraZeneca will pay $420 million to Moderna Therapeutics in a deal to develop drugs for a variety of diseases using a technology developed by Moderna, AstraZeneca said.

03/21/2013 - 10:38am

Alcon has launched a mobile website designed to facilitate dialogue between patients and pharmacists about eye and ear treatments, the company said.

03/18/2013 - 2:46pm

Drug maker GlaxoSmithKline's philanthropic arm has donated $500,000 to the Children's Hospital of Philadelphia as part of a fund that provides assistance to families for travel and living expenses they may incur while their children are enrolled in experimental or novel treatments offered at the hospital's Cancer Center.

03/18/2013 - 1:34pm

Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.